MCC Announces: New Track Added for Clinical Trial Risk and Performance Management Summit, Sept. 4-5, 2019, Philadelphia, PA

Come to Philadelphia Sept. 4-5 for the second-ever Metrics Champion Consortium Summit. This will be an exclusive gathering of the top minds in trial performance metrics, spearheaded by MCC Executive Director Linda Sullivan.

News provided by

Metrics Champion Consortium

Aug 08, 2019, 09:12 ET

FALLS CHURCH, Va., Aug. 8, 2019 /PRNewswire-PRWeb/ -- Clinical trial leaders in every biopharma company, large and small, are struggling with clinical trial performance metrics. Some are ahead of others, but few have mastered the art of turning metrics into process perfection.

Come to Philadelphia Sept. 4 and 5 for the second Metrics Champion Consortium Summit.
This will be an exclusive gathering of the top minds in trial performance metrics.

The summit begins with the first session Secrets to Implementing Successful Metric Programs, followed by the keynote session where Ken Getz — Associate Professor and Director, CSDD, Tufts University and Founder and Board Chair, CISCRP, clinical trials guru, founder of CenterWatch and an MCC partner — examines the patient engagement movement and its impact on clinical research execution.

The day continues with attendees picking the track that provides them with the information they need most: Vendor Oversight or Risk-Based Quality Management.

Vendor oversight is an all-new track developed to inform attendees on the impact of ICH E6(R2), developing healthy sponsor/vendor engagement and teams, clinical research organization (CRO) oversight and using metrics to manage vendor risk and performance.

  • Discuss current industry practices. Halloran Consulting will present the results of a detailed vendor oversight requirements survey and lead a conversation on current practices.
  • Explore the keys to developing healthy sponsor/vendor engagements and teams.
  • A sponsor-led case study takes participants through a real-life oversight journey via metrics from theory to practice.
  • An interactive small-group exercise helps uncover the root causes of issues using data reports to create action plans.
  • Examine how to use metrics to manage vendor risk and performance, including CRO metrics and designing metrics for all stakeholders.

Risk-based quality management focuses on emerging practices, the impact of ICH E6(R2) updates, risk management for small sponsors and developing and using a risk library. The breakout session topics provide opportunities to learn about:

  • Measuring centralized monitoring and site monitoring
  • Risk management for small sponsors
  • Development and use of a risk library
  • Keeping the risk assessment up to date
  • What skills are needed by clinical research associates (CRAs) and centralized monitors with risk-based site monitoring?
  • Applying artificial intelligence / machine learning to risk-based quality management
  • Coordinating the roles of sponsor and clinical research organization (CRO) in risk-based quality management
  • Challenges of gathering information to support risk evaluation

Choose a track and come away with the skills needed to master metrics. Attendees will receive a complimentary summit summary report post conference.

Who Will Benefit:
This event is designed for professionals from pharmaceutical, biotechnology and medical device companies; CROs; and other clinical service providers who have responsibilities in the following areas:

  • Clinical Operations/Management/ Research/Development
  • Clinical Outsourcing/Vendor Management/Third-Party Management
  • Clinical/Project Operations
  • Performance Analytics/Management/Reporting
  • Metric Reporting/Visualization
  • Quality Management/Clinical Quality Management
  • Compliance/Clinical Compliance/ Regulatory Compliance
  • Monitoring/Site Management/Study Management
  • Clinical Risk Assessment
  • Centralized Monitoring / Risk-based Monitoring
  • Good Clinical Practices
  • Clinical Process Optimization
  • Vendor Oversight

Conference Details:
Clinical Trial Risk and Performance Management Summit
**Presented by Metrics Champion Consortium**
Sept. 4-5, 2019 – Philadelphia, PA
http://www.fdanews.com/ctriskperformancemngmntsummit
Tuition:
Regular Pricing: $1,797
Significant team and MCC membership discounts are available.

Easy Ways to Register:
Online: http://www.fdanews.com/ctriskperformancemngmntsummit
By phone: 888-838-5578 or 703-538-7600

About MCC
Leading the drug-development enterprise in the adoption and utilization of standardized metrics and benchmarks to drive performance improvement. Founded in 2006, MCC is the leading industry association dedicated to the development of standardized performance metrics to improve clinical trials. MCC provides the collaborative environment for biopharmaceutical and device sponsors, service providers and sites to improve clinical-trial development through use of MCC standardized performance metrics.

SOURCE Metrics Champion Consortium